NEOSTIGMINE METHYLSULFATE

Neostigmine methylsulfate offers similar activity with better water solubility for injectable use. Side effects include sweating, nausea, slow heart rate, and muscle cramps.

SKU: 3495c37ab602 Category: Tag:

Product Description


Mechanism of Action

NEOSTIGMINE METHYLSULFATE (ID 26849) displays a broad-spectrum, multilayered biochemical interaction profile involving receptor-mediated signalling, enzymatic cascade modulation, mitochondrial redox-balance control, intracellular ion regulation, cytoskeletal architecture influence, and transcription-factor network modulation. Structural analysis suggests potential binding to catalytic residues, allosteric domains and regulatory scaffolding proteins, enabling the compound to alter phosphorylation–dephosphorylation kinetics, second‑messenger dynamics (Ca²⁺, IP₃, DAG, cAMP), ROS buffering capacity, and membrane-potential stabilization.

Depending on experimental concentration and cellular context, NEOSTIGMINE METHYLSULFATE may adjust ATP turnover rates, affect mitochondrial respiration, reshape metabolic routing, influence vesicular trafficking efficiency, and modulate gene‑expression clusters related to cellular survival, stress adaptation, inflammation, and metabolic equilibrium.

Benefits and Advantages

This compound is highly valuable for advanced mechanistic and preclinical research, including:

  • High‑resolution receptor–ligand binding and affinity‑mapping studies
  • Detailed enzymatic‑kinetic profiling and catalytic‑pathway deconstruction
  • Mitochondrial‑function analysis, ATP‑flux tracking and oxidative‑stress modelling
  • Integrated multi‑omics investigations (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal and membrane‑dynamics analysis involving actin and tubulin regulation
  • Apoptosis, autophagy, necroptosis, ferroptosis and other cell‑death pathway studies
  • Structure–activity relationship (SAR) assessment and molecular optimisation pipelines
  • Advanced pharmacodynamic simulations and mechanistic dose‑response scaling

Side Effects and Risks

Laboratory‑observed risks include:

  • Excessive ROS accumulation and oxidative‑stress imbalance
  • Mitochondrial hyperactivation or suppression of respiratory‑chain complexes
  • Disruption of Ca²⁺/Na⁺/K⁺ ionic homeostasis and channel regulation
  • Unintended receptor cross‑talk or inhibitory interference
  • Membrane‑integrity compromise and cytoskeletal destabilisation
  • Dose‑dependent cytotoxicity leading to apoptosis, autophagy or metabolic collapse
  • Inflammatory transcriptional activation (NF‑κB, JNK, p38 MAPK)

Extended exposure may trigger long‑term transcriptional rewiring, metabolic reprogramming or epigenetic instability. Use exclusively within controlled laboratory environments following strict biosafety protocols.

Datasheet


Molecular Formula

C13H22N2O6S

Molecular Weight

334.39 g/mol

CAS Number

51-60-5

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

>50.2 [ug/mL] (The mean of the results at pH 7.4)

Purity

Purity information is available upon request (COA).

Synonym

Neostigmine methyl sulfate; 51-60-5; NEOSTIGMINE METHYLSULFATE; Neostigmine metilsulfate; Syntostigmin

IUPAC/Chemical Name

[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;methyl sulfate

InChl Key

OSZNNLWOYWAHSS-UHFFFAOYSA-M

InChl Code

InChI=1S/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1

References

https://pubchem.ncbi.nlm.nih.gov/compound/5824;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download